Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SUMO1 anticorps

L’anticorps Souris Monoclonal anti-SUMO1 a été validé pour WB, IF, IHC, FACS et StM. Il convient pour détecter SUMO1 dans des échantillons de Humain et Rat.
N° du produit ABIN6940847

Aperçu rapide pour SUMO1 anticorps (ABIN6940847)

Antigène

Voir toutes SUMO1 Anticorps
SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))

Reactivité

  • 97
  • 79
  • 74
  • 6
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Humain, Rat

Hôte

  • 102
  • 33
  • 3
  • 1
  • 1
Souris

Clonalité

  • 94
  • 47
Monoclonal

Conjugué

  • 73
  • 10
  • 7
  • 6
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SUMO1 est non-conjugé

Application

  • 115
  • 50
  • 49
  • 42
  • 34
  • 27
  • 26
  • 23
  • 19
  • 13
  • 8
  • 7
  • 6
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (IHC), Flow Cytometry (FACS), Staining Methods (StM)

Clone

SM1-495
  • Specificité

    This MAb is specific to SUMO-1 and shows no cross-reaction with either SUMO-2 or SUMO-3. The small ubiquitin-related modifier (SUMO) proteins, which include SUMO-1, SUMO-2 and SUMO-3, belong to the ubiquitin-like protein family. Like ubiquitin, the SUMO proteins are synthesized as precursor proteins that undergo processing before conjugation to target proteins. Also, both utilize the E1, E2, and E3 cascade enzymes for conjugation. However, SUMO and ubiquitin differ with respect to targeting. Ubiquitination predominantly targets proteins for degradation, whereas sumoylation targets proteins to a variety of cellular processing, including nuclear transport, transcriptional regulation, apoptosis and protein stability. The unconjugated SUMO-1 protein localizes to the nuclear membrane.

    Réactivité croisée (Details)

    Predicted to show a broad species reactivity.

    Purification

    Purified by Protein A/G

    Immunogène

    Recombinant human SUMO1 protein

    Isotype

    IgG1 kappa
  • Indications d'application

    Positive Control: Breast Carcinoma.

    Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))

    Autre désignation

    SUMO1

    Poids moléculaire

    11.5kDa (Monomer), 90kDa (Heteromer)

    ID gène

    7341

    UniProt

    P63165

    Pathways

    M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway
Vous êtes ici:
Chat with us!